Expand MRNS Menu
MRNS MENU

MRNS Stock Summary and Trading Ideas (Marinus Pharmaceuticals | NASDAQ:MRNS)

Charts for Today's Stock Price and Implied Volatility in Marinus Pharmaceuticals

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for MRNS by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Marinus Pharmaceuticals (MRNS) Frequently Asked Questions

What does Marinus Pharmaceuticals do?

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.

What symbol and exchange does Marinus Pharmaceuticals shares trade?

Marinus Pharmaceuticals trades on the NASDAQ stock market under the symbol MRNS.

What is Marinus Pharmaceuticals stock price doing today?

As of December 16, 2024, MRNS stock price declined to $0.25 with 2,086,125 million shares trading.

What is Marinus Pharmaceuticals's Beta?

MRNS has a beta of 7.12, meaning it tends to be more sensitive to market movements. MRNS has a correlation of 0.14 to the broad based SPY ETF.

How much is Marinus Pharmaceuticals worth?

MRNS has a market cap of $13.67 million. This is considered a Sub-Micro Cap stock.

How much money does Marinus Pharmaceuticals make?

Last quarter Marinus Pharmaceuticals reported $9 million in Revenue and -$.42 earnings per share. This fell short of revenue expectation by $-877,000 and missed earnings estimates by -$.01.

What is the highest and lowest price Marinus Pharmaceuticals traded in the last 3 year period?

In the last 3 years, MRNS traded as high as $13.15 and as low as $.23.

What are the top ETFs holding Marinus Pharmaceuticals?

The top ETF exchange traded funds that MRNS belongs to (by Net Assets): VTI, VXF, IBB, IWC, ITOT.

Is Marinus Pharmaceuticals (MRNS) a good investment?

MRNS has underperformed the market in the last year with a price return of -97.2% while the SPY ETF gained +30.5%. MRNS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -83.5% and -23.7%, respectively, while the SPY returned +8.3% and +0.7%, respectively.

What are the support and resistance levels for Marinus Pharmaceuticals (MRNS)?

MRNS support price is $.25 and resistance is $.28 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MRNS shares will trade within this expected range on the day.